Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://barryexrn904548.jaiblogs.com/65951572/retaglutide-a-promising-glp-1-receptor-agonist